Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Neoplasm Metastasis 1Lung Neoplasms 1Hodgkin Disease 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

Carboplatin 29pembrolizumab 25Pemetrexed 25Specimen Handling 22Cisplatin 20Magnetic Resonance Spectroscopy 18Paclitaxel 15Gemcitabine 13Docetaxel 12durvalumab 9Nivolumab 8osimertinib 7Taxes 7Immunoglobulin G 7Disulfides 7130-nm albumin-bound paclitaxel 7atezolizumab 6Etoposide 6Platinum 5Cetuximab 51,2-diaminocyclohexaneplatinum II citrate 5X-Rays 4Ramucirumab 4Radiotherapy 4Radiation 4Observation 4Interviews as Topic 4Biopsy 4Albumin-Bound Paclitaxel 4patritumab deruxtecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Vinorelbine × 30 days × Clear all
NCT06632327 2026-06-02

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
1,100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡